These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 25936227)

  • 21. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
    Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ
    J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
    Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
    Trials; 2011 Jan; 12():4. PubMed ID: 21208417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rostral Anterior Cingulate Cortex Oscillatory Power Indexes Treatment-Resistance to Multiple Therapies in Major Depressive Disorder.
    Prentice A; Barreiros AR; van der Vinne N; Stuiver S; van Dijk H; van Waarde JA; Korgaonkar M; Sack AT; Arns M
    Neuropsychobiology; 2023; 82(6):373-383. PubMed ID: 37848013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstrating test-retest reliability of electrophysiological measures for healthy adults in a multisite study of biomarkers of antidepressant treatment response.
    Tenke CE; Kayser J; Pechtel P; Webb CA; Dillon DG; Goer F; Murray L; Deldin P; Kurian BT; McGrath PJ; Parsey R; Trivedi M; Fava M; Weissman MM; McInnis M; Abraham K; E Alvarenga J; Alschuler DM; Cooper C; Pizzagalli DA; Bruder GE
    Psychophysiology; 2017 Jan; 54(1):34-50. PubMed ID: 28000259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
    Etkin A; Patenaude B; Song YJ; Usherwood T; Rekshan W; Schatzberg AF; Rush AJ; Williams LM
    Neuropsychopharmacology; 2015 May; 40(6):1332-42. PubMed ID: 25547711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.
    Dunlop BW; Rajendra JK; Craighead WE; Kelley ME; McGrath CL; Choi KS; Kinkead B; Nemeroff CB; Mayberg HS
    Am J Psychiatry; 2017 Jun; 174(6):533-545. PubMed ID: 28335622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression.
    Maller JJ; Broadhouse K; Rush AJ; Gordon E; Koslow S; Grieve SM
    Mol Psychiatry; 2018 Aug; 23(8):1737-1744. PubMed ID: 29133948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CNS- and ANS-arousal predict response to antidepressant medication: Findings from the randomized iSPOT-D study.
    Olbrich S; Tränkner A; Surova G; Gevirtz R; Gordon E; Hegerl U; Arns M
    J Psychiatr Res; 2016 Feb; 73():108-15. PubMed ID: 26714202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
    Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM
    Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
    Grieve SM; Korgaonkar MS; Etkin A; Harris A; Koslow SH; Wisniewski S; Schatzberg AF; Nemeroff CB; Gordon E; Williams LM
    Trials; 2013 Jul; 14():224. PubMed ID: 23866851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.
    Cook IA; Hunter AM; Gilmer WS; Iosifescu DV; Zisook S; Burgoyne KS; Howland RH; Trivedi MH; Jain R; Greenwald S; Leuchter AF
    J Clin Psychiatry; 2013 Jan; 74(1):51-6. PubMed ID: 23419226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.
    Shilyansky C; Williams LM; Gyurak A; Harris A; Usherwood T; Etkin A
    Lancet Psychiatry; 2016 May; 3(5):425-35. PubMed ID: 26995298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between the Rostral Anterior Cingulate Cortex and Anterior Insula in the Salience Network on Response to Antidepressants in Major Depressive Disorder as Revealed by Isolated Effective Coherence.
    Minami S; Kato M; Ikeda S; Yoshimura M; Ueda S; Koshikawa Y; Takekita Y; Kinoshita T; Nishida K
    Neuropsychobiology; 2022; 81(6):475-483. PubMed ID: 35878584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report.
    Braund TA; Palmer DM; Williams LM; Harris AWF
    Psychol Med; 2020 Apr; 50(6):1032-1042. PubMed ID: 31023398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.
    Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB
    Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment.
    Saveanu R; Etkin A; Duchemin AM; Goldstein-Piekarski A; Gyurak A; Debattista C; Schatzberg AF; Sood S; Day CV; Palmer DM; Rekshan WR; Gordon E; Rush AJ; Williams LM
    J Psychiatr Res; 2015 Feb; 61():1-12. PubMed ID: 25586212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis.
    Pizzagalli D; Pascual-Marqui RD; Nitschke JB; Oakes TR; Larson CL; Abercrombie HC; Schaefer SM; Koger JV; Benca RM; Davidson RJ
    Am J Psychiatry; 2001 Mar; 158(3):405-15. PubMed ID: 11229981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disrupted causal connectivity anchored on the anterior cingulate cortex in first-episode medication-naive major depressive disorder.
    Feng Z; Xu S; Huang M; Shi Y; Xiong B; Yang H
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():124-30. PubMed ID: 26234517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression.
    Saletu B; Anderer P; Saletu-Zyhlarz GM
    Clin EEG Neurosci; 2010 Oct; 41(4):203-10. PubMed ID: 21077572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain electrical source differences between depressed subjects and healthy controls.
    Korb AS; Cook IA; Hunter AM; Leuchter AF
    Brain Topogr; 2008 Dec; 21(2):138-46. PubMed ID: 18958615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.